Navigation Links
BBIC – A SOY-based Substance Treats Multiple Sclerosi

Bowmann-Birk Inhibitor Concentrate (BBIC) is a natural soy-based substance. A US based study finds: BBIC improves the condition of animals with a disease similar to multiple// sclerosis.

A group of animals with Autoimmune Encephalomyelitis (EAE) received BBIC, while another group of animals also suffering from the same disease received a placebo.

"Animals that received BBIC were able to walk, while those that didn't get the drug were not," said the study leader Dr. A.M. Rostami, professor and chairperson of the department of Neurology at Jefferson Medical College in Philadelphia.

The animals that received BBIC were able to walk though with some limp or weakness. Although they were’nt completely cured, the results are promising, the researchers said.

It was also found that the CNS of the animals that received BBIC had "significantly less inflammation and demyelination" than animals that hadn't received BBIC.

"It's the first time that BBIC has been used in an EAE model and has shown significant disease suppression, and we hope it can eventually be used in humans," Rostami said.

BBIC inhibits secretion of Proteases, a group of enzymes that are responsible for the inflammation and demyelination associated with multiple sclerosis (MS), a condition which causes inflammation in the myelin coating of nerve fibers.
PRI
'"/>




Page: 1

Related medicine news :

1. Substance abuse linked to adult antisocial syndrome
2. UV- Light Tanning As A Type Of Substance-Related Disorder
3. Homeless People More Prone To Substance Abuse
4. Substance Abuse Prevention Messages Better Received Among Teenagers in the Form of Media Campaigns and Curriculum
5. Using Herbal Products Heightens Substance Abuse Risk in Teens
6. Healthcare Worker Arrested For Administering Noxious Substances
7. Better Screening Now Possible For ADHD In Adult Substance Users
8. More Medicines Found To Contain Toxic Substance
9. Substance P May Pre-empt VIP in Regulating Temperature
10. Fact Sheet on Polonium-210 - The Substance That Killed Former Russian Spy
11. Natural Brain Substance Linked to Parkinsons Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... ... June 28, 2017 , ... The parent company ... in employee engagement. Omaha-based C&A Industries, a national leader in staffing and ... in North America for 2017. The annual award, issued by Achievers, ...
(Date:6/28/2017)... Church, VA (PRWEB) , ... June 28, 2017 , ... ... http://www.fdanews.com/fdaeumdregs      , No matter on which side of the Atlantic devicemakers ... medical device regulations they have to follow. , In addition to the full text ...
(Date:6/28/2017)... ... June 28, 2017 , ... Eating disorders have the highest mortality ... at least one person dies as a direct result from an eating disorder in ... qualified treatment providers. The iaedp Foundation meets this challenge by offering what has become ...
(Date:6/28/2017)... ... June 28, 2017 , ... American Farmer proudly announces the participation of ... winning television series, scheduled to broadcast fourth quarter 2017. American Farmer airs Tuesdays at ... supplier of garden pea seed. As demand grew, the small company located in Moscow, ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... insurance management and financial planning assistance to clients in southern Montana, is announcing ... offered by Zoo Montana. , The outreach programs offered by Zoo Montana provide ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... of two Phase 2 trials of its RSV F protein ... child bearing age have been published in the journal ... have been shared in prior scientific conferences). The Company previously ... April 2014. Novavax is developing the RSV F Vaccine with ...
(Date:6/2/2017)... Mass. , June 2, 2017  NxStage Medical, ... renal care, today announced new findings demonstrating positive biochemical ... ® System One™. The data will be presented ... in Madrid, Spain . ... to Improve Home Dialysis Network in Europe ...
(Date:5/29/2017)...  Cellect Biotechnology Ltd. (NASDAQ: APOP ; TASE: ... functional selection of stem cells, today provided a corporate ... ended March 31 st , 2017. ... first quarter of 2017," said Dr. Shai Yarkoni, Chief ... treatment of the first blood cancer patient in the ...
Breaking Medicine Technology: